(PDF) Serum Cytokine Levels as Predictive Biomarkers of

Serum Cytokine Levels as Predictive Biomarkers of Benefit From Ipilimumab in Small Cell Lung Cancer

OncoImmunology - United States

doi 10.1080/2162402x.2019.1593810

Full Text

Abstract

Available in full text

Categories

Date

March 27, 2019

Authors

Max Hardy-Werbin

Xavier Villanueva

Deborah Joseph-Pietras

Richard Griffiths

Miguel Lopez-Botet

Christian Ottensmeier

Publisher

Informa UK Limited

Related search

Predictive Role of Plasmatic Biomarkers in Advanced Non-Small Cell Lung Cancer Treated by Nivolumab

English

Plasma microRNAs as Potential Biomarkers for Non-Small-Cell Lung Cancer

Laboratory Investigation

Forensic Medicine

Molecular Biology

English

Using Biomarkers Serum Prognostic Factors for Non-Small Cell Lung Cancer: A Surgical Perspective

Annals of Thoracic Surgery

Respiratory Medicine

Cardiovascular Medicine

English

Identification of Gene Biomarkers for Distinguishing Small-Cell Lung Cancer From Non-Small-Cell Lung Cancer Using a Network-Based Approach

BioMed Research International

Molecular Biology

English

Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy

English

Prm158 - Predictive Biomarkers of Treatment Success in Advanced Non–small Cell Lung Cancer Patients Using Multivariate Causal Inference.

Value in Health

Occupational Health

English

miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives

Targeted Oncology

Cancer Research

English

P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit From Nivolumab in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

English